STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #276 by analyst upside · 2026-09-14
CNXU
Conexeu Sciences Inc.
Healthcare · Market Cap $126M · P/E 0x
ANALYST PRICE TARGET
+348.4%
implied upside to consensus target
Current Price $4.46
Consensus Target $20.0
Bull Target $20.0
Bear Target $20.0
Analysts Covering 1
ANALYST CONSENSUS - BUY
Strong Buy
0
Buy
1
Hold
0
Sell
0
52-Week Low $4.19
52-Week High $18.79
YTD Return -65.9%
FUNDAMENTALS
Market Cap $126M
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-0.34
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) N/A
Profit Margin N/A
52-WEEK RANGE
52-Week Low $4.19
52-Week High $18.79
Current Price $4.46
Bear Target $20.0
Bull Target $20.0
● Now $4.46 ● Target $20.0
TRADING DATA
Avg Volume 172K
YTD Return -65.9%
Analyst Count 1
Consensus Buy
Upside to Target +348.4%
Last Updated 2026-09-14

ANALYST SUMMARY

Conexeu Sciences Inc. (CNXU) is currently trading at $4.46 with a Wall Street consensus price target of $20.0, implying potential upside of 348.4% over the next 12 months. 1 analysts currently cover CNXU, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $20.0, while the most cautious has a target of $20.0.

CNXU operates in the Healthcare sector with a market capitalisation of $126M. The stock is down 65.9% year-to-date and is currently trading near the lower end of its 52-week range of $4.19 – $18.79.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for CNXU, with each firm's 90-day track record across all stocks we track. See full firm rankings →

HC Wainwright & Co. ● Initiated
Buy 2026-06-22 31% win rate (48 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
40
out of 100
Coverage depth
5/30
Consensus clarity
8/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →